David Breen's profile picture

Dr. David Breen

  • Senior Clinical Research Fellow

Organisation Associations

Centre for Clinical Brain Sciences
Anne Rowling Regenerative Neurology Clinic
Edinburgh Neuroscience
School of Regeneration and Repair
Usher Institute
School of Neurological and Cardiovascular Sciences

Current research interests

Dundee and Edinburgh Parkinson’s Research Initiative: I am a Lead Clinical Investigator for this partnership between two Scottish universities. We are developing a prospective, longitudinal, integrated health and research informatics platform for Parkinson’s in the East of Scotland: Clinical Audit Research Evaluation – Parkinson’s Disease (CARE-PD). In collaboration with Dr. Esther Sammler (Dundee) and Dr. Gordon Duncan (Edinburgh), this research-ready cohort will drive research advances and clinical trials in our local population. By collaborating with researchers worldwide, we are using this real-world data to help accurately model the natural history of PD. We are part of the Rostock International Parkinson’s Disease Study (ROPAD) and PD-FRONTLINE (I am local PI for both) which will identify and treat genetic PD subtypes (GBA and LRRK2 patients). We are building on recent laboratory findings to explore the disease-modifying potential of the probiotic Bacillus Subtilis in PD (collaboration with Dr. Maria Doitsidou, Edinburgh and Prof. Guido Alves, Stavanger). I am co-Chief Investigator for the Scottish Regenerative Neurology Tissue Bank.

 

Sleep and circadian rhythm dysfunction in PD: My Wellcome Trust-funded fellowship uses big data from existing cohort studies to assess whether sleep and circadian disruption in healthy individuals (measured using questionnaires and activity monitors) influences brain health, both cross-sectionally (neuropsychological performance, brain imaging) and longitudinally (incident disease, brain pathology). I previously led a study to define the sleep phenotype of early PD and showed that sleep disturbances were associated with a fundamental change in patient’s hormone and clock gene profile. 

 

RT-QuIC as a diagnostic biomarker: In collaboration with Dr. Alison Green (Edinburgh), I am evaluating the RT-QuIC assay in a variety of biofluids for the diagnosis of synucleinopathies (including PD and Multiple System Atrophy).

 

Understanding PD dementia: Under the leadership of Prof. Roger Barker (Cambridge) and Prof. David Burn (Newcastle), I previously worked on a longitudinal cohort study (ICICLE-PD) which has made significant contributions to our understanding of the mechanisms and predictors of cognitive impairment in PD. I remain involved in this project, which forms part of the Dementias Platform UK.

 

Communication failure in PD: In collaboration with Dr. Angela Roberts (Northwestern University) and Dr. Saturnino Luz (Edinburgh), we are carrying out a project to define the causes and consequences of communication failure in PD (using home voice recordings) and how these relate to cognitive phenotype and social relationships.

Research in a nutshell

I am an academic neurologist in the field of movement disorders, focussing on Parkinson's disease (PD). I have diverse research interests including studying the influence of sleep and circadian disruption on brain health; studying genetic and environmental PD risk factors using large datasets; and studying neglected non-motor PD features (such as dementia and communication problems). I am driving the development of PD clinical research in Edinburgh and helping to increase clinical trials capacity. I am committed to patient participation in research.

Full research profile, including publications